Prediction of Medication Compliance Following Renal Transplantation

This pilot study is intended to provide preliminary data about the feasibility of recruiting a cohort of subjects on hemodialysis and following them prospectively through the transplant procedure. The study will document patient adherence to medications and treatment, both before and after surgery. These preliminary data will permit appropriate design and power calculations for a future study assessing our ability to predict post-transplant compliance, based on pre-transplant behaviors.

Inclusion criteria

• Adult hemodialysis patients in renal transplant evaluation
• Able to read test forms
• Responsible for their own medications

Exclusion criteria

• Patients with a major risk of recurrent primary renal disease, e.g. hemolytic uremic syndrome, oxalosis, membranoproliferative glomerulonephritis type II, focal segmental glomerulosclerosis with nephrotic syndrome.
• Patients with active psychosis
• Patients who do not speak English.
• Patients who live and will be followed outside the United States, except Canada.
• Patients who are physically unable to open the Medication Event Monitoring System (MEMS) cap.
• Patients who are not responsible for taking their own medications, e.g. living in a medical care facility.
• Patients who are younger than 14 years old
• Patients who will receive an extra renal organ (except pancreas), either simultaneously or previously.